EMEA-000429-PIP01-08-M04
Key facts
Invented name |
Nimenrix
|
Active substance |
|
Therapeutic area |
Vaccines
|
Decision number |
P/0089/2015
|
PIP number |
EMEA-000429-PIP01-08-M04
|
Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
Condition(s) / indication(s) |
Prevention of Meningococcal disease
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
GlaxoSmithKline Biologicals SA
Tel. +44 (0)20 8966 3220 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000429-PIP01-08-M04
|
Compliance opinion date |
26/04/2019
|
Compliance outcome |
positive
|